These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 14960647)

  • 41. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
    Gerety EL; Lawrence EM; Wason J; Yan H; Hilborne S; Buscombe J; Cheow HK; Shaw AS; Bird N; Fife K; Heard S; Lomas DJ; Matakidou A; Soloviev D; Eisen T; Gallagher FA
    Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.
    Storto G; Gallicchio R; Pellegrino T; Nardelli A; De Luca S; Capacchione D; Sirignano C; Pace L
    Nucl Med Biol; 2013 May; 40(4):518-23. PubMed ID: 23522973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of (18)F-fluoride PET/CT over dual-phase bone scintigraphy in evaluation and management of lesions causing foot and ankle pain.
    Kim JY; Choi YY; Kim YH; Park SB; Jeong MA
    Ann Nucl Med; 2015 Apr; 29(3):302-12. PubMed ID: 25547254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases].
    Falaschi F; Battolla L; Zampa V; Cioni R; Cambi L; Antonelli A; Bartolozzi C
    Radiol Med; 1996 Dec; 92(6):713-8. PubMed ID: 9122459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis.
    Liu NB; Zhu L; Li MH; Sun XR; Hu M; Huo ZW; Xu WG; Yu JM
    Asian Pac J Cancer Prev; 2013; 14(6):3647-52. PubMed ID: 23886160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ¹⁸F-Fluoride PET/CT is highly effective for excluding bone metastases even in patients with equivocal bone scintigraphy.
    Bortot DC; Amorim BJ; Oki GC; Gapski SB; Santos AO; Lima MC; Etchebehere EC; Barboza MF; Mengatti J; Ramos CD
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1730-6. PubMed ID: 22949079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.
    Withofs N; Grayet B; Tancredi T; Rorive A; Mella C; Giacomelli F; Mievis F; Aerts J; Waltregny D; Jerusalem G; Hustinx R
    Nucl Med Commun; 2011 Mar; 32(3):168-76. PubMed ID: 21076343
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A meta-analysis of (18)F-Fluoride positron emission tomography for assessment of metastatic bone tumor.
    Tateishi U; Morita S; Taguri M; Shizukuishi K; Minamimoto R; Kawaguchi M; Murano T; Terauchi T; Inoue T; Kim EE
    Ann Nucl Med; 2010 Aug; 24(7):523-31. PubMed ID: 20559896
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 18F-Fluoride PET/CT allows detection of hyperostosis and osseous involvement in meningioma: initial experience.
    Tateishi U; Tateishi K; Shizukuishi K; Shishikura A; Murata H; Inoue T; Kawahara N
    Clin Nucl Med; 2013 Mar; 38(3):e125-31. PubMed ID: 23412601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Malignant involvement of the spine: assessment by 18F-FDG PET/CT.
    Metser U; Lerman H; Blank A; Lievshitz G; Bokstein F; Even-Sapir E
    J Nucl Med; 2004 Feb; 45(2):279-84. PubMed ID: 14960648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
    Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
    BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18F-fluoride uptake in bone metastasis: morphologic and metabolic analysis on integrated PET/CT.
    Kawaguchi M; Tateishi U; Shizukuishi K; Suzuki A; Inoue T
    Ann Nucl Med; 2010 May; 24(4):241-7. PubMed ID: 20333485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.
    Yun M; Kim W; Alnafisi N; Lacorte L; Jang S; Alavi A
    J Nucl Med; 2001 Dec; 42(12):1795-9. PubMed ID: 11752075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
    Haroon A; Syed R; Endozo R; Allie R; Freeman A; Emberton M; Bomanji J
    Nucl Med Commun; 2017 May; 38(5):407-414. PubMed ID: 28379896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
    Langsteger W; Balogova S; Huchet V; Beheshti M; Paycha F; Egrot C; Janetschek G; Loidl W; Nataf V; Kerrou K; Pascal O; Cussenot O; Talbot JN
    Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):448-57. PubMed ID: 21738117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ¹⁸F-fluoride PET/computed tomography imaging.
    Even-Sapir E
    PET Clin; 2014 Jul; 9(3):277-85. PubMed ID: 25030391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The diagnostic performance of
    Liu Y; Sheng J; Dong Z; Xu Y; Huang Q; Pan D; Wang L; Yang M
    Clin Radiol; 2019 Mar; 74(3):196-206. PubMed ID: 30648535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 18F-Labeled NaF PET-CT in Detection of Bone Metastases in Patients With Preoperative Lung Cancer.
    Rao L; Zong Z; Chen Z; Wang X; Shi X; Yi C; Zhang X
    Medicine (Baltimore); 2016 Apr; 95(16):e3490. PubMed ID: 27100456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative diagnostic value of 18F-fluoride PET-CT versus MRI for skull-base bone invasion in nasopharyngeal carcinoma.
    Le Y; Chen Y; Zhou F; Liu G; Huang Z; Chen Y
    Nucl Med Commun; 2016 Oct; 37(10):1062-8. PubMed ID: 27159589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
    Moragas M; Soler M; Riera E; García JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.